Sitagliptin in T1D: In a crossover pilot study, eight weeks of treatment with sitagliptin 100 mg daily in 20 adults with T1D reduced postprandial and 24-h glycemia and reduced prandial insulin requirements significantly. Here, INS is linked to type 1 diabetes mellitus.